Series A · AI & Machine Learning · Paris, France · Founded 2019 · 11–50 employees
Kiro is Europe's first AI-powered digital health platform for clinical biology, founded in 2019 by Alexandre Guenoun (ex-Oliver Wyman). The company uses artificial intelligence to transform complex laboratory test results into clear, personalized insights for patients and actionable recommendations for doctors. Their AI model was trained on over 26 million lab reports and serves over 150,000 monthly active users, partnering with leading hospitals including the American Hospital of Paris. The company raised €13.8 million in Series A funding led by Sofinnova Partners in 2023, bringing total funding to over €17 million, and was selected twice for the prestigious French Tech 2030 program.